谷歌浏览器插件
订阅小程序
在清言上使用

Safety of BXCL701, a Small Molecule Inhibitor of Dipeptidyl Peptidases (DPP), with Pembrolizumab, (pembro, Anti-Pd-1) Monoclonal Antibody, in Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc).

Journal of Clinical Oncology(2020)

引用 1|浏览61
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要